Michael R Shurin
University of Pittsburgh, USA
Biography
After graduation from Moscow State Medical School in 1984, Post graduation training in clinical Biochemistry and Clinical Immunology and obtaining his PhD degree in Immunopharmacology in 1991, He joined the Faculty of the Department of Pathology at the University of Pittsburgh Medical Center in 1991 where he is a Professor of Pathology and Immunology and an Associate Director of the Division of Clinical Immunopathology. His main research interests are in the field of the tumour microenvironment, cancer-mediated immunomodulation and dendritic cell vaccines for cancer immunotherapy. At present, his research program focuses on the immune modulating properties of chemotherapy and modulation of the tumour micro environmental elements, including dendritic cells, regulatory T cells, myeloid-derived suppressor cells and endothelial cells, as well as intratumoral cytokine network. Using a combination of immunological, molecular and gene therapeutic methodologies, He is an Author of more than hundred peer-reviewed publications and numerous reviews, an editor of several books, including “Dendritic Cell in Cancer” and “The tumour immune environment” books, an organizer of several popular international conferences on Immune-Mediated Diseases, Immunodiagnostics and Immuno monitoring and Cancer Immunotherapy. He is a Member of several grant review and editorial boards and many clinical and research societies.
Abstract
Abstract : Pharmacological regulation of the tumor immunoenvironment
